A Comparative Effectiveness Study of Mortality Outcomes and Related Cardiopulmonary Events Among a Cohort of Chronic Obstructive Pulmonary Disease (COPD) Patients who Initiate Breztri and Multiple Inhaler Triple Therapy (MITT) in the United States (US)

Trial Identifier: D5980R00098
Sponsor: AstraZeneca
Start Date: February 2024
Primary Completion Date: March 2024
Study Completion Date: March 2024
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States, Delaware Wilmington, Delaware, United States, 19803